Javascript must be enabled to continue!
Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy
View through CrossRef
We hereby report a case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy (CSC). Issues regarding safety and adverse effects of bevacizumab are discussed. To the best of our knowledge, this is the first reported case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal CSC.
Title: Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy
Description:
We hereby report a case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal central serous chorioretinopathy (CSC).
Issues regarding safety and adverse effects of bevacizumab are discussed.
To the best of our knowledge, this is the first reported case of hemorrhagic macular infarction after intravitreal bevacizumab for chronic multifocal CSC.
Related Results
Effect of intravitreal bevacizumab injection in central serous chorioretinopathy
Effect of intravitreal bevacizumab injection in central serous chorioretinopathy
AbstractPurposeTo investigate the effect of intravitreal bevacizumab injection on the type of central serous chorioretinopathy.MethodsWe performed a retrospective analysis of 43 pa...
Randomized Study of Intravitreal Injection of Bevacizumab in the Treatment of Persistent Uveitic Macular Edema
Randomized Study of Intravitreal Injection of Bevacizumab in the Treatment of Persistent Uveitic Macular Edema
Objective: To assess the efficacy and safety of Bevacizumab IVT in the treatment of persistent uveitic macular edema Methods: This is a prospective randomized interventional study...
Off-label intravitreal brolucizumab and bevacizumab for chronic central serous chorioretinopathy
Off-label intravitreal brolucizumab and bevacizumab for chronic central serous chorioretinopathy
AIM: To compare the intravitreal brolucizumab and bevacizumab injections for chronic central serous chorioretinopathy (cCSC).
METHODS: Patients with cCSC were classified into bevac...
Abstract 2099: Model-riven optimization of anti-angiogenics combined with chemotherapy: application to bevacizumab + pemetrexed/cisplatin doublet in NSCLC-bearing mice
Abstract 2099: Model-riven optimization of anti-angiogenics combined with chemotherapy: application to bevacizumab + pemetrexed/cisplatin doublet in NSCLC-bearing mice
Abstract
Bevacizumab-containing protocols are all based upon the concomitant administration of the drugs given in a row. Bevacizumab is expected to induce a transien...
ELONGATED PHOTORECEPTOR OUTER SEGMENT LENGTH AND PROGNOSIS OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
ELONGATED PHOTORECEPTOR OUTER SEGMENT LENGTH AND PROGNOSIS OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
Purpose:
To evaluate the effect of elongated photoreceptor outer segment length on the visual prognosis of patients with chronic central serous chorioretinopathy after ...
Refractory Serositis In Gorham-Stout Syndrome
Refractory Serositis In Gorham-Stout Syndrome
Abstract
Background: Gorham-Stout syndrome (GSS) is a rare disorder with various presentations and unpredictable prognoses. Previous understandings of GSS mainly focused on...
Early avastin (Bevacizumab) Administration for acute retinal vein occlusion: A key strategy for improved patient outcomes.
Early avastin (Bevacizumab) Administration for acute retinal vein occlusion: A key strategy for improved patient outcomes.
Objective: To find the mean change in BCVA and CMT after intravitreal injection Avastin administration in patients with acute retinal vein occlusion with macular edema. Study Desig...
Reflux after intravitreal injection: an anterior segment optical coherence tomography study
Reflux after intravitreal injection: an anterior segment optical coherence tomography study
Purpose: To investigate the intraocular pressure and conjunctival thickness changes following the intravitreal injection Methods: Sixty eyes of 60 patients having intravitreal inj...

